Quel est le prix pour Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Le prix pour Lushang Freda Pharmaceutical Co.,Ltd. (600223) est $0.83325484

Quelle est la capitalisation boursière pour Lushang Freda Pharmaceutical Co.,Ltd. (600223)

La capitalisation boursière pour Lushang Freda Pharmaceutical Co.,Ltd. (600223) est $847.06M

Revenus de Lushang Freda Pharmaceutical Co.,Ltd. (600223)

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.

Année	Revenus	Changez
Pas assez de données pour les dates fournies.

Année

Revenus

Changez

Pas assez de données pour les dates fournies.

Entreprise	Revenus	Différence de revenus	Pays
Sun Hung Kai Properties Limited 0016.HK	$11.88B	-	HK
China Resources Land Limited 1109.HK	$40.22B	-	HK
Emaar Properties PJSC EMAAR.AE	-	-	AE
CK Asset Holdings Limited 1113.HK	$9.53B	-	HK
Sumitomo Realty & Development Co., Ltd. 8830.T	$6.82B	-	JP

Entreprise

Revenus

Différence de revenus

Pays